Nexus Surgical

{
  "main_header": {
    "sid": 105611,
    "name": "Nexus Surgical",
    "stock_name": "Nexus Surgical",
    "full_name": "Nexus Surgical and Medicare Ltd",
    "name_url": "stocks-analysis/nexus-surgical",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "17.55",
    "chg": -0.72,
    "chgp": "-3.94%",
    "dir": -1,
    "prev_price": "18.27",
    "mcapval": "10.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 538874,
    "symbol": "",
    "ind_name": "Non Banking Financial Company (NBFC)",
    "ind_code": 5,
    "indexname": "India SENSEX",
    "isin": "INE370Q01015",
    "curr_date": "Apr 10",
    "curr_time": "",
    "bse_nse_vol": "110 ",
    "exc_status": "Active",
    "traded_date": "Apr 10, 2026",
    "traded_date_str": "2026 04 10",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/nexus-surgical-105611-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Nexus Surgical and Medicare Ltd Upgraded to Sell Amid Mixed Technicals and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nexus-surgical-and-medicare-ltd-upgraded-to-sell-amid-mixed-technicals-and-valuation-concerns-3929587",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NexusSurgicalan_mojoScore_3929587.png",
        "date": "2026-04-02 08:05:02",
        "description": "Nexus Surgical and Medicare Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 1 April 2026, driven primarily by changes in its technical outlook despite persistent fundamental challenges. The micro-cap NBFC’s technical indicators have shifted from mildly bullish to sideways, prompting a reassessment of its near-term prospects amid flat financial performance and valuation concerns."
      },
      {
        "title": "Nexus Surgical and Medicare Ltd Downgraded to Strong Sell Amid Technical and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nexus-surgical-and-medicare-ltd-downgraded-to-strong-sell-amid-technical-and-valuation-concerns-3917644",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NexusSurgicalan_mojoScore_3917644.png",
        "date": "2026-03-26 08:03:35",
        "description": "Nexus Surgical and Medicare Ltd, a micro-cap player in the Non-Banking Financial Company (NBFC) sector, has been downgraded from a Sell to a Strong Sell rating as of 25 March 2026. The revision reflects a deterioration in technical indicators, valuation concerns, and a flat financial trend, despite the company’s historically strong returns over the long term. This comprehensive analysis explores the four key parameters that triggered the rating change: Quality, Valuation, Financial Trend, and Technicals."
      },
      {
        "title": "Nexus Surgical and Medicare Ltd Upgraded to Sell on Technical Improvements",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nexus-surgical-and-medicare-ltd-upgraded-to-sell-on-technical-improvements-3879190",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NexusSurgicalan_mojoScore_3879190.png",
        "date": "2026-03-09 08:02:54",
        "description": "Nexus Surgical and Medicare Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 6 March 2026, driven primarily by improvements in technical indicators despite persistent valuation and financial trend challenges. The company’s technical outlook has shifted to mildly bullish, prompting a reassessment of its near-term prospects, although fundamental concerns remain."
      },
      {
        "title": "Nexus Surgical and Medicare Ltd Forms Golden Cross, Signalling Potential Bullish Breakout",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nexus-surgical-and-medicare-ltd-forms-golden-cross-signalling-potential-bullish-breakout-3876274",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NexusSurgicalan_goldencross_3876274.png",
        "date": "2026-03-06 18:55:06",
        "description": "Nexus Surgical and Medicare Ltd, a micro-cap player in the Non Banking Financial Company (NBFC) sector, has recently formed a Golden Cross—a significant technical indicator where the 50-day moving average crosses above the 200-day moving average. This development often heralds a bullish breakout, signalling a potential long-term momentum shift and trend reversal for the stock."
      },
      {
        "title": "Nexus Surgical and Medicare Ltd Downgraded to Strong Sell Amid Technical and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nexus-surgical-and-medicare-ltd-downgraded-to-strong-sell-amid-technical-and-valuation-concerns-3857346",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NexusSurgicalan_mojoScore_3857346.png",
        "date": "2026-02-26 08:02:20",
        "description": "Nexus Surgical and Medicare Ltd, a player in the Non Banking Financial Company (NBFC) sector, has seen its investment rating downgraded from Sell to Strong Sell as of 25 February 2026. This shift reflects a combination of deteriorating technical indicators, expensive valuation metrics, flat financial trends, and weakening overall quality scores, signalling caution for investors amid a challenging market environment."
      },
      {
        "title": "Nexus Surgical and Medicare Ltd Upgraded to Sell on Technical Improvements and Valuation Insights",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nexus-surgical-and-medicare-ltd-upgraded-to-sell-on-technical-improvements-and-valuation-insights-3851055",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NexusSurgicalan_mojoScore_3851055.png",
        "date": "2026-02-23 08:03:45",
        "description": "Nexus Surgical and Medicare Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 20 Feb 2026, driven primarily by a shift in technical indicators signalling a mild bullish trend. Despite this upgrade, the company continues to face valuation and fundamental challenges, with flat recent financial performance and a high price-to-book ratio. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that influenced the rating change and what it means for investors."
      },
      {
        "title": "Nexus Surgical and Medicare Ltd Downgraded to Strong Sell Amid Technical and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nexus-surgical-and-medicare-ltd-downgraded-to-strong-sell-amid-technical-and-valuation-concerns-3843687",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NexusSurgicalan_mojoScore_3843687.png",
        "date": "2026-02-17 08:10:00",
        "description": "Nexus Surgical and Medicare Ltd, a player in the Non Banking Financial Company (NBFC) sector, has seen its investment rating downgraded from Sell to Strong Sell as of 16 February 2026. This shift reflects a combination of deteriorating technical indicators, expensive valuation metrics, flat financial trends, and weakening overall quality assessments, signalling caution for investors amid a challenging market backdrop."
      },
      {
        "title": "Are Nexus Surgical and Medicare Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-nexus-surgical-and-medicare-ltd-latest-results-good-or-bad-3840301",
        "imagepath": "",
        "date": "2026-02-14 19:36:28",
        "description": "Nexus Surgical's latest financial results for Q2 FY26 present a complex picture. The company reported a net profit of ₹0.17 crores, reflecting a sequential increase of 13.33% from the previous quarter, while revenue for the same period was ₹1.17 crores, which marked a significant decline of 32.37% compared to Q1 FY26. Year-over-year, however, revenue showed an improvement of 18.18% from ₹0.99 crores in Q2 FY25.\n\nOperating margins have expanded notably, reaching 20.51%, up from 12.14% in the prior quarter, indicating enhanced efficiency in operations. The profit after tax (PAT) margin also improved to 14.53%, up from 8.67% in Q1 FY26. This margin expansion, despite the revenue contraction, raises questions about the sustainability of the company's business model, especially given its low promoter holding of 18.73% and lack of institutional backing.\n\nThe financial performance indicates a volatility in revenue..."
      },
      {
        "title": "Nexus Surgical and Medicare Ltd Upgraded to Sell on Technical Improvement Despite Flat Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nexus-surgical-and-medicare-ltd-upgraded-to-sell-on-technical-improvement-despite-flat-financials-3834384",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NexusSurgicalan_mojoScore_3834384.png",
        "date": "2026-02-12 08:05:57",
        "description": "Nexus Surgical and Medicare Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators signalling a mild bullish trend. Despite this positive technical momentum, the company continues to face challenges in valuation and financial performance, which temper the overall outlook for investors."
      }
    ],
    "total": 161,
    "sid": "105611",
    "stock_news_url": "https://www.marketsmojo.com/news/nexus-surgical-and-medicare-105611"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "08-Apr-2026",
      "details": "Submission of Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 31st March 2026",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "27-Mar-2026",
      "details": "Intimation for Closure of Trading Window for the quarter ended 31st March 2026.",
      "source": "BSE"
    },
    {
      "caption": "Results - Financial Results For 31-12-2025",
      "datetime": "14-Feb-2026",
      "details": "Submission of Unaudited Quarterly Financial Results of the Company for the quarter and nine months ended 31st December 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Nexus Surgical and Medicare Ltd Upgraded to Sell Amid Mixed Technicals and Valuation Concerns

2026-04-02 08:05:02

Nexus Surgical and Medicare Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 1 April 2026, driven primarily by changes in its technical outlook despite persistent fundamental challenges. The micro-cap NBFC’s technical indicators have shifted from mildly bullish to sideways, prompting a reassessment of its near-term prospects amid flat financial performance and valuation concerns.

Read full news article

Nexus Surgical and Medicare Ltd Downgraded to Strong Sell Amid Technical and Valuation Concerns

2026-03-26 08:03:35

Nexus Surgical and Medicare Ltd, a micro-cap player in the Non-Banking Financial Company (NBFC) sector, has been downgraded from a Sell to a Strong Sell rating as of 25 March 2026. The revision reflects a deterioration in technical indicators, valuation concerns, and a flat financial trend, despite the company’s historically strong returns over the long term. This comprehensive analysis explores the four key parameters that triggered the rating change: Quality, Valuation, Financial Trend, and Technicals.

Read full news article

Nexus Surgical and Medicare Ltd Upgraded to Sell on Technical Improvements

2026-03-09 08:02:54

Nexus Surgical and Medicare Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 6 March 2026, driven primarily by improvements in technical indicators despite persistent valuation and financial trend challenges. The company’s technical outlook has shifted to mildly bullish, prompting a reassessment of its near-term prospects, although fundamental concerns remain.

Read full news article

Nexus Surgical and Medicare Ltd Forms Golden Cross, Signalling Potential Bullish Breakout

2026-03-06 18:55:06

Nexus Surgical and Medicare Ltd, a micro-cap player in the Non Banking Financial Company (NBFC) sector, has recently formed a Golden Cross—a significant technical indicator where the 50-day moving average crosses above the 200-day moving average. This development often heralds a bullish breakout, signalling a potential long-term momentum shift and trend reversal for the stock.

Read full news article

Nexus Surgical and Medicare Ltd Downgraded to Strong Sell Amid Technical and Valuation Concerns

2026-02-26 08:02:20

Nexus Surgical and Medicare Ltd, a player in the Non Banking Financial Company (NBFC) sector, has seen its investment rating downgraded from Sell to Strong Sell as of 25 February 2026. This shift reflects a combination of deteriorating technical indicators, expensive valuation metrics, flat financial trends, and weakening overall quality scores, signalling caution for investors amid a challenging market environment.

Read full news article

Nexus Surgical and Medicare Ltd Upgraded to Sell on Technical Improvements and Valuation Insights

2026-02-23 08:03:45

Nexus Surgical and Medicare Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 20 Feb 2026, driven primarily by a shift in technical indicators signalling a mild bullish trend. Despite this upgrade, the company continues to face valuation and fundamental challenges, with flat recent financial performance and a high price-to-book ratio. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that influenced the rating change and what it means for investors.

Read full news article

Nexus Surgical and Medicare Ltd Downgraded to Strong Sell Amid Technical and Valuation Concerns

2026-02-17 08:10:00

Nexus Surgical and Medicare Ltd, a player in the Non Banking Financial Company (NBFC) sector, has seen its investment rating downgraded from Sell to Strong Sell as of 16 February 2026. This shift reflects a combination of deteriorating technical indicators, expensive valuation metrics, flat financial trends, and weakening overall quality assessments, signalling caution for investors amid a challenging market backdrop.

Read full news article

Are Nexus Surgical and Medicare Ltd latest results good or bad?

2026-02-14 19:36:28

Nexus Surgical's latest financial results for Q2 FY26 present a complex picture. The company reported a net profit of ₹0.17 crores, reflecting a sequential increase of 13.33% from the previous quarter, while revenue for the same period was ₹1.17 crores, which marked a significant decline of 32.37% compared to Q1 FY26. Year-over-year, however, revenue showed an improvement of 18.18% from ₹0.99 crores in Q2 FY25. Operating margins have expanded notably, reaching 20.51%, up from 12.14% in the prior quarter, indicating enhanced efficiency in operations. The profit after tax (PAT) margin also improved to 14.53%, up from 8.67% in Q1 FY26. This margin expansion, despite the revenue contraction, raises questions about the sustainability of the company's business model, especially given its low promoter holding of 18.73% and lack of institutional backing. The financial performance indicates a volatility in revenue...

Read full news article

Nexus Surgical and Medicare Ltd Upgraded to Sell on Technical Improvement Despite Flat Financials

2026-02-12 08:05:57

Nexus Surgical and Medicare Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators signalling a mild bullish trend. Despite this positive technical momentum, the company continues to face challenges in valuation and financial performance, which temper the overall outlook for investors.

Read full news article

View All News